• N. Stepanova SI «Institute of Nephrology NAMS of Ukraine»
  • O. Burdeyna SI «Institute of Nephrology NAMS of Ukraine»
  • V. Driyanska SI «Institute of Nephrology NAMS of Ukraine»
  • V. Savchenko SI «Institute of Nephrology NAMS of Ukraine»
  • M. Kolesnyk SI «Institute of Nephrology NAMS of Ukraine»
Keywords: peritoneal dialysis, peritonealfibrosis, monocytic chemoattractant protein-1, interleukin-10.


Peritonealfibrosis (PF) is a common morphological change in peritoneal dialysis (PD) patients. With the progression of PF, peritoneal membrane function is impaired, which leads to ultrafiltration failure. Results of studies in recent years show the crucial role of high production monocytic chemoattractant protein -1 (MCP-1) of peritoneal fibrosis in PD-patients. The aim was to determine intraperitoneally production ofIL-10 and MCP-1 and its relationship with clinical and laboratory parameters of adequacy of dialysis.

Patients and methods. A prospective observational study involved 18patients with CKD stage Vwith non-diabetic nephropathy, were treated with continuous ambulatory peritoneal dialysis (PAPD). The limits of the normal range (reference range) were obtained from the survey results of 10 conditionally healthy individuals. ELISA method in serum and peritoneal dialysis effluent (PDE) investigated levels ofIL-10 and MSP-1. PAPD adequacy indicators evaluated by determining the concentration of urea and creatinine in plasma, urine and dialysate, calculated weekly creatinine clearance (CrCl), dialysis (Ш/ Vd), renal (Ш / Vr) and шА weekly urea clearance (Kt/ V). 

Results. In all of the PD-patients compared to healthy donors conventionally, there was a significant increase in concentration of the cytokines. We determined the positive regression relationship between the concentration of MCP-1 and IL-10 in PDE and the level of total weekly (Kt / V) and renal (Kt / Vr).

Conclusions. We determined the regression dependence, which allowed to identify clinical parameters that are most closely (statistically significant) related to intraperitoneal production of MCP-1 and IL-10.


Download data is not yet available.


Андру сев А. М. Перитонеальный диализ: отдаленные результаты лечения, факторы, их определяющие, и клиническая патофизиология метода / А. М. Андрусев // Нефрология и диализ. – 2005. – Т. 7. – № 2. – С. 110–129.

Національний реєстр хворих на хронічну хворобу нирок та пацієнтів з гострим пошкодженням нирок: 2015 рік / уклад. Н. І. Козлюк [та ін.]; Академія медичних наук України, Міністерство охорони здоров’я України, Державна установа «Інститут нефрології НАМН України»; гол. ред. М. О. Колесник. – К., 2016. – 200 с. – 40 прим.

Aguilera A. Epithelial to mesenchymal transition as a triggering factor of peritoneal membrane fibrosis and angiogenesis in peritoneal dialysis patients / Aguilera A., Yanez-Mo M., Selgas R., [et al.] // Curr Opin Investig Drugs. – 2005. – Vol.6. – P. 262-268.

Aroeira L.S. Epithelial to mesenchymal transition and peritoneal membrane failure in peritoneal dialysis patients: pathologic significance and potential therapeutic interventions / Aroeira L.S., Aguilera A., Sanchez-Tomero J.A., [et al.] // J Am Soc Nephrol. - 2007. - Vol. 18. - P. 2004-2013.

Clinical outcomes and mortality in elderly peritoneal dialysis patients / Tamer Sakac, Elbis Ahbap, Yener Koc , Taner Basturk., [et al] // Clinics. – 2015. - Vol. 70(5). - P. 363-368.

Collins A.J. Mortality Risks of Peritoneal Dialysis and Hemodialysis / Collins A.J., Hao W., Xia H., Ebben J.P., Everson S.E., Constantini E.G., Ma J.Z. // Am J Kidney Dis. 1999. - Vol.36. - P. 1065-1074.

Gilberto Baroni. Inflammation and the Peritoneal Membrane: Causes and Impact on Structure and Function during Peritoneal Dialysis / Gilberto Baroni, Adriana Schuinski, Thyago P. de Moraes, // Mediators Inflamm.

Küper. NFAT5 Contributes to Osmolality-Induced MCP-1 Expression in Mesothelial Cells / Küper, Christoph, Franz-X. Beck, Wolfgang Neuhofer // Mediators of Inflammation. - Mode of access:

Liem Y.S. Comparison of hemodialysis and peritoneal dialysis survival in The Netherlands / Liem Y.S., Wong J.B., Hunink M.G., de Charro F.T., Winkelmayer W.C. // Kidney International. - 2007. - Vol. 71. - P. 153-158.

Liu Y. Transition of Mesothelial Cell to Fibroblast in Peritoneal Dialysis: EMT, Stem Cell or Bystander? / Liu Y., Dong Z., Liu H., Zhu J., Liu F., Chen G. // Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis. - 2015. - Vol. 35(1). - P. 14-25.

Malik A.R. Peritonitis, peritoneal inflammation and membrane permeability: a longitudinal study of dialysate and serum MCP-1 in stable patients on peritoneal dialysis / Malik A.R., Little M.A., Henriksson M., Tam F.W., Brown E.A. // J Nephrol. - 2007. - Vol. 20(3). - P.340-9.

Molecular Mechanisms Underlying Peritoneal EMT and Fibrosis (Electronic resource) / Raffaele Strippoli, Roberto Moreno-Vicente, [et al.] / Stem Cells International. – V. 2016. – Mode of access:

Onishi A. Attenuation of methylglyoxal-induced peritoneal fibrosis: immunomodulation by interleukin-10 / Onishi A., Akimoto T., Urabe M., Hirahara I., Muto S., Ozawa K., Nagata D., Kusano E. // Lab Invest. – 2015. – Vol. 95(12). – P. 1353-62.

Renal replacement therapy in Ukraine: epidemiology and international comparisons / Kolesnyk I., Noordzij M., Kolesnyk M., Kulyzky M., Jager K. // Clinical Kidney Journal. – 2014. – Vol. 7(3). – P. – 330-335.

Ronco C. Adequacy of peritoneal dialysis is more than Kt/V / Ronco C // Nephrol Dial Transplant. – 1997. – Vol.12 (1). – P.68-73.

Ryouji Ogata. Impairment of MCP-1 expression in mesothelial cells exposed to peritoneal dialysis fluid by osmotic stress and acidic stress / Ryouji Ogata, Nobuhiko Hiramatsu, Kunihiro Hayakawa, Shotaro Nakajima, Jian Yao, Tetsuro Kobayashi, Masanori Kitamura // Perit Dial Int. – 2011. – Vol. 31(1). – P. 80-89

Selgas R. Epithelial-to-mesenchymal transition of the mesothelial cell - its role in the response of the peritoneum to dialysis / Selgas R, Bajo A, Jimenez- Heffernan JA, [et al.] // Nephrol Dial Transplant. – 2006. – Vol. – 21(2). – P. 112-117.

Si-Yen Tan. Optimization of peritoneal dialysis services through research activities / Si-Yen Tan. // Perit Dial Int. – 2008. – Vol. 28(3). – P. 49-52.

Witowski J. New Developments in Peritoneal Fibroblast Biology: Implications for Inflammation and Fibrosis in Peritoneal Dialysis / Witowski J., Kawka E., Rudolf A., Jorres A. // BioMed Research International. – 2015. – Vol. 10. – P. 1155-2015.

Abstract views: 280
PDF Downloads: 128
How to Cite
Stepanova, N., Burdeyna, O., Driyanska, V., Savchenko, V., & Kolesnyk, M. (2016). SYSTEMIC EFFECTS OF LOCAL PRODUCTIONOFPRO- AND ANTI-FIBROGENIC MEDIATORS IN PERITONEAL DIALYSIS PATIENTS. Ukrainian Journal of Nephrology and Dialysis, (4(52), 52-58.

Most read articles by the same author(s)

1 2 > >>